Inherited renal tubular disorders associated with hypokalemic alkalosis (Bartter-like syndromes) can be subdivided into at least three clinical phenotypes: (i) the hypocalciuric-hypomagnesemic Gitelman variant; (ii) the classic variant; and (iii) the antenatal hypercalciuric variant (also termed hyperprostaglandin E syndrome). Mutations in the Na-CI cotransporter (NCCT) underlie the pathogenesis of the Gitelman variant and mutations in the Na-K-2CI cotransporter (NKCC2) have recently been identified in the antenatal hypercalciuric variant. We now describe mutations in the gene encoding the inwardly-rectifying potassium channel, ROMK, in eight kindreds with the antenatal variant of Bartter syndrome. These findings indicate that antenatal Bartter syndrome is genetically heterogeneous and provide new insights into the molecular pathogenesis of Bartter-like syndromes.
INTRODUCTION
Bartter syndrome encompasses a set of primary renal tubular disorders associated with hypokalemic metabolic alkalosis; often increased urinary prostaglandin excretion; hyperreninemic hyperaidosteronism with normal blood pressure; and hypexplasia of the juxtaglomerular apparatus (1) . Within this relatively rare set of disorders, familial cases occur commonly and inheritance best fits with autosomal recessive transmission (2, 3) , This set of disorders can be subdivided into at least three clinical phenotypes: (i) the hypocalciuric-hypomagnesemic variant described by Gitelman et aL\ (ii) the classic syndrome originally described by Bartter et aL; and (iii) the antenatal hypercalciuric variant associated with severe systemic manifestations (3) (4) (5) (6) .
Among these disorders, Gitelman syndrome is characterized by a relatively mild course and late age of onset. Profound hypokalemia and hypomagnesemia lead to the major manifestations of fatigue, muscle weakness and recurrent episodes of tetany (7, 8) . Hypocalciuria and mildly impaired urinary concentrating ability are constant features of this sub-type (9) . Recent studies demonstrate that this disorder results from presumptive loss o f function mutations in the gene encoding the thiazide-sensitive sodium-chloride (Na-Cl) cotransporter (NCCT) of the distal nephron (10) . Genetic homogeneity in Gitelman syndrome has been confirmed in subsequent studies ( 11, 12) .
In comparison, patients with classic Bartter syndrome (CBS) generally present during early childhood. These patients fulfill the core criteria of Bartter's original description without Table 1 . Clinical characteristics of index patients with antenatal Bartter syndromea associated tetanic episodes or profound hypercalciuria (3, 6, 13) . Typically, urinary calcium excretion is normal or slightly elevated and urinary concentrating capacity is close to normal (9, 14) . While much attention has been focused on defective chloride transport in the medullary thick ascending limb of the loop of Henle (mTAL) as the proximate abnormality in CBS (15) (16) (17) (18) , the underlying defect in the classic variant remains to be elucidated.
Finally, the antenatal variant of Bartter syndrome (ABS) is a life-threatening disorder in which both the renal tubular hypokalemic alkalosis as well as profound systemic symptoms are manifest (5, 19, 20) . The abnormalities begin in utero with marked fetal polyuria that leads to polyhydramnios between 24 and 30 weeks gestation and typically, premature delivery (5, (19) (20) (21) . The amniotic fluid contains high chloride levels but normal concentrations of sodium, potassium, calcium and prostaglandin E? (22) . Affected neonates have severe salt wasting and hyposthenuria, moderate hypokalemic metabolic alkalosis, hyperprostaglandinuria and failure to thrive. An essential manifestation is matted hypercalciuria and as a secondary consequence affected infants develop nephrocalcinosis and osteopenia (23-26). The fever, vomiting and occasional diarrhoea associated with this disorder has been attributed to the stimulation of renal and systemic prostaglandin E2 activity in affected infants and these symptoms are effectively treated with inhibitors of prostaglandin synthesis. Based on these clinical features, the term hyperprostaglandin E syndrome was coined to describe this antenatal variant of Bartter syndrome (27 Recent studies have demonstrated mutations in the gene encoding the mTAL luminal bumetanide-sensitive Na'K-2Cl cotransporter (.NKCC2) in a cohort of five ABS kindreds (28) . These genetic data indicate that the antenatal variant of Bartter syndrome results from a primary defect in mTAL chloride transport. This hypothesis is consistent with clinical studies demonstrating that ABS patients have an impaired diuretic response to furosemide (29) . However, in applying haplotype analyses with polymorphic chromosome 15 markers tightly linked to NKCC2 in our cohort of 14 antenatal Bartter syndrome families, we excluded NKCC2 as the disease-susceptibility locus in six families.
Transepithelial chloride transport in the mTAL involves an inteiplay between the apical Na-K-2C1 cotransporter (NKCC2), the luminal, ATP-regulated potassium channel, ROMK (KCNJ1), the basolateral chloride channel (C/C), a basolateral K~C1 cotransporter, and the Na-K-ATPase (reviewed in 30,31). Therefore, defective chloride transport may result from loss of function mutations in any of the genes encoding these channels or cotransporters. We now report the identification of mutations in the ROMK gene (.KCNJ1) in three kindreds and five sporadic cases with ABS. These findings indicate that the antenatal variant of Bartter syndrome is genetically heterogeneous.
RESULTS

Antenatal Bartter syndrome kindreds
We have identified a cohort of 14 families with antenatal Bartter syndrome and five sporadic cases for study (Table 1 ). In nine of these families, the affected children were the products of consanguineous unions. All index cases had a history of polyhydramnios and premature delivery. Postnatally, patients developed hypokalemic alkalosis and all had hyposthenuria.
Prior to the initiation of indomethacin therapy, all affected infants had failed to thrive with growth parameters less than the third percentile for age. Urinary excretion rates of prostaglandin E2 (PGE2) and/or its major metabolite, prostaglandin E-M (PGE-M) were markedly elevated (100% above upper limit of normal) in all patients in whom these measurements were performed. gene interval (Fig. 1 ). Of note, there were no clinical or laboratory features that distinguish the group linked to NKCC2 and the group unlinked to this locus (Table 1) .
In those families where the NKCC2 gene is excluded as the disease-susceptibility locus, we evaluated whether ABS is linked to the gene encoding ROMK, the inwardly-rectifying, ATP-regulated, potassium channel. Fluorescence in situ hybridization has ■ mapped the ROMK gene, KCNJ1, to chromosome llq24-25 (32, 33) . Therefore, we typed these families for a set of five microsatellite markers that spanned a 14 cM candidate interval on The largest product, ROMK-1, is initiated at a start codon in exon 4, contains 391 amino acid residues, and is the most efficiently translated isoform (34) . Based on the sequence of ROMK-1, sets of primer pairs were used to amplify the coding sequence for exon 4 and exon 5 from genomic DNA of our test families ( Table 2 ). The amplified products were analyzed by single-strand conformation polymorphism analysis (SSCA). Aberrant SSCA patterns were detected for exon 5 in three consanguineous families (AB.Paris2, AB.Marb3 and AB.Marb4) and the five sporadic cases. The affected children in the consanguineous families were homozygous for these aberrations. None of these aberrant SSCA patterns has been observed in examination of at least 50 normal unrelated Caucasian controls (100 test alleles).
In total, 11 mutations were identified and four of these mutations were homozygous (Table 3 ; Fig. 3 ). Sequence analysis reveals that these mutations are distributed throughout the ROM K-1 protein (Fig. 4) . Nine mutations are missense, causing substitutions of residues which are highly conserved in wild-type human, rat and Xenopus laevis. One mutation introduces a stop codon that deletes the terminal 63 residues of the channel protein and one 4 bp deletion causes a frameshift that results in a truncated, 351 amino acid protein. All of these mutations were inferred to alter the ROM K protein structure.
Mutations in the KCNJI gene have not been detected in families AB.ParisS, AB.Paris6 or AB.MarbS. It is possible that these families have KCNJI gene mutations involving the exon-intron splice junctions of exon 4 or exon 5 or in an as yet unexamined exon. In addition, we cannot exclude the possibility that another gene may be the disease-susceptibility locus in these families.
DISCUSSION
Antenatal Bartter syndrome is aphenotypically distinct variant of the Bartter-like syndromes characterized by polyhydramnios with preterm delivery, severe salt wasting, hyposthenuria, and hypercalciuria ( Table 1 ). Our identification of 11 independent mutations in the gene KCNJI that segregate specifically with ABS and result in either non-conservative amino acid substitu tions in important functional domains or premature truncation of the channel protein indicate that defects in KCNJI cause the antenatal variant of Bartter syndrome. These findings demon strate that ABS is genetically heterogeneous, involving mutations in KCNJI as well as NKCC2 (28) . Sense strand sequences are shown. Amino acids are numbered from the first Met in exon 4. The mutation # refers to the mutation position in Figure 4 . Nucleotides are numbered as in Shuck et a I. (34) .
The ROMK gene is a disease-susceptibility gene in antenatal Bartter syndrome KCNJI encodes the luminal, ATP-sensitive, potassium channel in the distal nephron (35) (36) (37) . This channel belongs to a family of inwardly rectifying potassium channels (Kir family; ROMK is Kir 1.1) and is characterized by little-to-no voltage dependence, inward rectification, exquisite pH-sensitivity and modulation by ATP (31, (38) (39) (40) . The ROM K channel is involved in potassium secretion in the TAL and the distal nephron. In the mTAL, this secretory function recycles potassium across the apical mem brane, thus ensuring that adequate luminal potassium is available for the efficient functioning of the Na-K-2C1 cotransporter (41) . Inhibition of luminal potassium channels reduces NaCl reabsorp tion in this nephron segment (42) . In human kidney, differential splicing produces five distinct transcripts of ROMK. While the relative distribution of these isoforms in distal nephron segments has not been established, exon 5 is common to all of these isoforms and encodes the majority of the channel protein (33, 34) .
The detection of 11 independent mutations involving this common exon predicts that ROMK activity is disrupted in our cohort of ABS patients.
We have identified mutations involving the amphipathic MO segment; the M l and M2 transmembrane segments; the M1-H5 linker segment that comprises the channel pore; the putative ATP-binding domain; and the C-terminus of the ROMK channel protein (Fig. 4) . Two non-conservative missense mutations within the MO region of the N-terminus have been identified, V72G (mutation #5 in Table 3 , Fig. 4 ) and D74Y (mutation #11). This region of ROMK has been implicated in internal pH regulation of ROMK (43) . Since this channel is exquisitely sensitive to reductions in cytosolic pH, these mutations in MO could significantly alter ROMK channel function. The homo zygous missense mutation, W99C (mutation #8), that involves the substitution of a polar cystine for Trp-99 in the M l domain is likely to alter the configuration of the channel pore and thus, would be predicted to disrupt channel function. The missense mutations in AB.Marb4 (mutation #3), AB.MarbS 1 (mutation #4) and AB.ParisSl (mutation #10) all cause non-conservative amino acid changes in the M1-H5 linker region. Experimental studies have demonstrated that this segment is important in external pH regulation of the inwardly-rectifying potassium channels, HIR (44) and ROMK. Mutation of the glycosylation site, Asn-117, in this region of ROMK has been shown to single channel conductance and ion selectivity (37) . Within the M2 transmembrane segment, prior tn xtnt mutagenesis studies have indicated that residue <11x167 is oriented so that it faces the •* channel pore (46K Therefore, the homozygous mutation* G 167E (mutation #2). that substitutes a glutamic aekl with its large polar R group for City-IC»7 would ix? predicted to alter the pore conformation arui tints, he deleterious for channel function. The non-conservative substitution within a 63 amino acid segment that lies just 3' to the M2 domain and is involved in RO M K channel regulation, This regulatory region contains important phosphorylation sites [two protein kinase C (PKC) and one protein kinase À (PKA) sites] and a M g2+~ATP-binding motif (Walker A site) that have been shown to be important in the non-hydrolytie M g2+-ATP regulation of R O M K (37). Both PKA (35, 47) and PKC (37, 48) are important regulators of RO M K function and structural alterations due to non-conservative amino acid substitutions within this region may disrupt channel regulation. O f note, the same A198T mutation was found in a homozygous missense mutation* AlWF (mutation #1 h causes a non-related compound heterozygote (AB.FreiS 1 ). That this M arW , a Cl to C change in the lirst lusv ot uHl**n Mis llw ^iihattunon> DIUKtl ianti n*nse strand data shown). OM hi the compound heterozygote, AB.Marb.S2, the fust mutant allele has a T to Ci miitation ut v »ni« m i 15 te^uUmg m the V i 15CÌ substttution. tn the seciutd nuitant allele, a 4 bp deletion produces a t rameshifi in codon 334, whieheauses the premature termination oi the pmicm iantr^n*»e Mriiml data shown*. I El In the cointHUiiul heten»/ygote. AH.l;re iS l. the fust mutant allele has the same G to A change in codon WN as AIU M m 2, ir ailtiui* m thr A IM M ^uhstmttuin (anti sense strami data shown), tn the second mutant allele, a C to T change in the first base of codon 33N intriHÌikVH a -.top f F* In AlJ.NiiSK a fomio/ygou^ (♦ to T mutation in the last base of codon W causes the change.
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Human Molecular Genetics, 1997, Vol. 6, No. 1 specific point mutation occurs in two unrelated families and is not evident in 100 test chromosomes provides further supporting evidence that this mutation is pathogenic and not simply a polymorphism. Finally, we have identified three mutant alleles that alter the C-terminus of the ROMK protein. Since the C-terminus has been shown to be important in determining pore properties (49), mutations in this region could affect channel function. In one mutant allele, a 4 bp deletion (mutation #7) causes a frameshift mutation at codon 334 and results in the introduction of a termination codon 36 amino acids downstream. In another mutant allele, a stop codon is substituted at R338 (mutation #9), thereby deleting the terminal 53 residues of the carboxy tail. These two mutations could alter phosphorylation at the tyrosine kinase site at Y337, which is conserved in rat and human ROMK. In the third mutant allele, a glycine for Val-315 substitution (mutation #6) lies adjacent to the cyclic AMP-de pendent PKA phosphorylation site in the carboxy tail which has been shown to be critical for channel function (47) . In all affected individuals, these mutations would be predicted to cause loss of function in the channel protein.
Proposed pathogenesis of antenatal variant of Bartter syndrome
In the mTAL, the functional coupling of ROMK and the luminal Na-K-2C1 cotransporter (NKCC2) is crucial for NaCI reabsorp tion. Therefore, loss of function in ROMK as well as NKCC2 (28) would be predicted to disrupt electrogenic chloride reabsorption in the mTAL. A primary defect in mTAL chloride transport is consistent with the complex constellation of features evident in ABS patients. Several lines of evidence support this proposed pathogenic model. Chronic inhibition of salt reabsorption in the mTAL by long-term furosemide treatment mimics the clinical and bio chemical findings in ABS, i.e. hypokalemic hypochloremic alkalosis, hypo-or isosthenuria, and impaired renal conservation of both calcium and magnesium (5, 50, 51) . Furthermore, ABS patients have impaired diuretic, saluretic and hormonal responses to furosemide (29) . In contrast, furosemide sensitivity is main tained in Gitelman syndrome (52), which is caused by mutations in the thiazide-sensitive Na-Cl cotransporter of the distal convoluted tubule ( 10) .
In patients with either KCNJl or NKCC2 mutations, defective mTAL chloride transport results in increased NaCI delivery to the distal nephron with consequent salt wasting, loss of concentrating capacity and volume contraction. In addition, impaired electro genic chloride transport in mTAL also inhibits the voltage-driven, paracellular re absorption of calcium and magnesium (53) , thus leading to hypercalciuria and in some patients, hypermagnesuria. In ABS, stimulation of renal and systemic PGE2 formation is likely to be a secondary phenomenon, at least in those patients with KCNJl or NKCC2 mutations. The elevated PGE2 levels play a central role in disease pathogenesis (16, 27) . Experimental data demonstrate that elevated PGE2 activity stimulates the reninangiotensin-aldosterone axis (54) , specifically inhibits ROMK channel activity (48,55) and impedes NaCI transport in the mTAL (56, 57) , as well as vasopressin-induced water reabsortion in the collecting duct (58) . Therefore, stimulation of PGE2 activity exacerbates the primary defect in mTAL chloride transport, contributes to the aldosterone-mediated hypokalemic metabolic alkalosis and promotes hyposthenuria. As would be predicted, suppression of PGE2 formation with cyclo-oxygenase inhibitors, such as indomethacin, attenuates the salt wasting and hypoka lemic alkalosis and converts hyposthenuria to isosthenuria (29) , In summary, our identification of molecular defects in the KCNJl gene, coupled with the previously reported mutations in NKCC2 (28) , indicate that antenatal Bartter syndrome is geneti cally heterogeneous. Together, these data support the hypothesis that ABS involves a primary mTAL transport defect (29) . While we cannot exclude the possibility that there may be additional gene defects that cause ABS, these data provide new insights into the complex, interrelated mechanisms involved in the pathogene sis of antenatal Bartter syndrome. In addition, our findings expand the genetic basis for distinguishing Bartter-like syn dromes from one another. While specific disorders within the spectrum of Bartter-like syndromes can usually be differentiated by applying rigorous clinical criteria, confounding presentations are not unusual. Further identification of the basic genetic defects in Bartter-like syndromes will provide potential molecular tools for distinguishing specific disorders within this often confusing spectrum, and for dissecting the complicated pathophysiology involved in each disorder.
MATERIALS AND METHODS
Bartter syndrome families
Index cases from families, AB . cen\roma:e«DllS934-DllS912-DUS874-DllS910-~DllS1320-te\omero.
Microsatellite polymorphisms were amplified by the polymer ase chain reaction using forward primers labeled at the 5'-end either with fluorescent dye or y-32P. PCR reactions were performed in a 15 pil volume containing 50 ng of genomic DNA, 1.5 mM MgCl2, 5 mM Tris (pH 8.3), 50 mMKCl, 10 pmol of each primer and 0.5 U of Taq polymerase. After an initial denaturation step at 94°C for 5 min, PCR was conducted for 30 cycles with dénaturation at 94°C for 45 s, annealing at 55°C for 45 s and extension at 72 °C for 45 s. The reaction was completed with a final elongation step at 72°C for 10 rain. Amplified products were separated on 6% polyacrylamide gels run under denaturing conditions. The gels were analyzed either using the Genscan 672 software (Ver 1.2) or autoradiography. Linkage analysis was performed using the LINKAGE programs (61). Haplotypes were constructed from the genotype data. The most likely haplotypes were inferred by minimizing the number of crossover events in each sibship.
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SSCA and DNA sequencing Aberrant band patterns for the KCNJ1 gene were sought using single-strand conformation polymorphism analysis (SSCA) (62).
Based on the sequence for the human KCNJI gene previously described (34) , an overlapping set of primer pairs were designed (Table 2 ) and used to amplify the coding sequence for exons 4 and 5 from genomic DNA of our test families as well as 50 unrelated controls. PCR was performed as described above except that the products were labeled by inclusion of I jiCi of [a-32P]dCTP or [a-^P]dCTP in the reaction mixture. Amplified products were separated either at room temperature or at 4°C by electrophoresis at 40 W constant power for 6-8 h on 0.5x MDE gels (AT Biochem) prepared in 0.6x TBE 154 mM Tris borate (pH 7.8)]. Following autoradiography, conformational variants were ex cised from the gel and the DNA was isolated by centrifugation through a Micropure 0.22 filter (Amicon, Inc.). The isolated product was then re-amplified with the same primer pair and subjected to direct DNA sequence analysis using an ABI 373A automated DNA sequencer (Applied Biosystems). Alternatively, non-radioactive PCR was performed and gels were silver-stained as previously described (63) . Direct sequencing was performed after reamplification of the remaining PCR product using a direct blotting electrophoresis sequencing system (GATC 1500, GATC, Konstanz, Germany). In all cases, DNA sequences were con firmed by sequencing both strands.
